OBJECTIVES: To examine the association between hypertension and cognitive decline in older adults. DESIGN: Prospective observational study. SETTING: Four rural counties in China. PARTICIPANTS: Two thousand rural Chinese aged 65 and older (median age 70, range 65-92) participated in a baseline evaluation. A follow-up evaluation of 1,737 subjects was conducted 2.5 years after baseline. MEASUREMENTS: Cognitive function was assessed using the Community Screening Instrument for Dementia (CSID), Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word List Learning and Recall Tests, Indiana University (IU) Story Recall Test, Animal Fluency Test, and IU Token Test. Hypertension was defined as the mean of two readings of systolic blood pressure (BP) of 140 mmHg or greater, diastolic BP of 90 mmHg or greater, or according to self-report. Cognitive decline was derived as the difference between baseline and follow-up scores. Analysis of covariance models were used to estimate the association between hypertension, BP, and cognitive decline, adjusting for other covariates. RESULTS: Greater decline was found on the CERAD 10-Word List Learning (P<.001) and Recall (P=.01) scores for subjects with hypertension than for those without. In particular, significantly greater decline was seen in the group with hypertension that was not taking medication than in the group without hypertension. No significant difference on cognitive decline was found between subjects with hypertension who were taking medication and those without hypertension. CONCLUSION: Untreated hypertension was associated with greater cognitive decline in this Chinese cohort. Better hypertension detection and treatment in elderly people, especially in developing countries, may offer protection against cognitive decline.
OBJECTIVES: To examine the association between hypertension and cognitive decline in older adults. DESIGN: Prospective observational study. SETTING: Four rural counties in China. PARTICIPANTS: Two thousand rural Chinese aged 65 and older (median age 70, range 65-92) participated in a baseline evaluation. A follow-up evaluation of 1,737 subjects was conducted 2.5 years after baseline. MEASUREMENTS: Cognitive function was assessed using the Community Screening Instrument for Dementia (CSID), Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word List Learning and Recall Tests, Indiana University (IU) Story Recall Test, Animal Fluency Test, and IU Token Test. Hypertension was defined as the mean of two readings of systolic blood pressure (BP) of 140 mmHg or greater, diastolic BP of 90 mmHg or greater, or according to self-report. Cognitive decline was derived as the difference between baseline and follow-up scores. Analysis of covariance models were used to estimate the association between hypertension, BP, and cognitive decline, adjusting for other covariates. RESULTS: Greater decline was found on the CERAD 10-Word List Learning (P<.001) and Recall (P=.01) scores for subjects with hypertension than for those without. In particular, significantly greater decline was seen in the group with hypertension that was not taking medication than in the group without hypertension. No significant difference on cognitive decline was found between subjects with hypertension who were taking medication and those without hypertension. CONCLUSION: Untreated hypertension was associated with greater cognitive decline in this Chinese cohort. Better hypertension detection and treatment in elderly people, especially in developing countries, may offer protection against cognitive decline.
Authors: C L Emsley; S Gao; Y Li; C Liang; R Ji; K S Hall; J Cao; F Ma; Y Wu; P Ying; Y Zhang; S Sun; F W Unverzagt; C W Slemenda; H C Hendrie Journal: Am J Epidemiol Date: 2000-05-01 Impact factor: 4.897
Authors: Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Christophe Tzourio; Craig Anderson; Neil Chapman; Mark Woodward; Bruce Neal; Stephen MacMahon; John Chalmers Journal: Arch Intern Med Date: 2003-05-12
Authors: Ruth Peters; Nigel Beckett; Francoise Forette; Jaakko Tuomilehto; Robert Clarke; Craig Ritchie; Adam Waldman; Ivan Walton; Ruth Poulter; Shuping Ma; Marius Comsa; Lisa Burch; Astrid Fletcher; Christopher Bulpitt Journal: Lancet Neurol Date: 2008-07-07 Impact factor: 44.182
Authors: Emily Frith; Nitin Shivappa; Joshua R Mann; James R Hébert; Michael D Wirth; Paul D Loprinzi Journal: Br J Nutr Date: 2018-01-24 Impact factor: 3.718
Authors: A Ogunniyi; K A Lane; O Baiyewu; S Gao; O Gureje; F W Unverzagt; J R Murrell; V Smith-Gamble; K S Hall; H C Hendrie Journal: Acta Neurol Scand Date: 2011-02-08 Impact factor: 3.209
Authors: Lindsay R Clark; Rebecca L Koscik; Samantha L Allison; Sara E Berman; Derek Norton; Cynthia M Carlsson; Tobey J Betthauser; Barbara B Bendlin; Bradley T Christian; Nathaniel A Chin; Sanjay Asthana; Sterling C Johnson Journal: Alzheimers Dement Date: 2018-10-25 Impact factor: 21.566
Authors: Hai Liu; Sujuan Gao; Kathleen S Hall; Frederick W Unverzagt; Kathleen A Lane; Christopher M Callahan; Hugh C Hendrie Journal: J Am Geriatr Soc Date: 2013-05-06 Impact factor: 7.538